Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth

Jiayi Wu,Chuanmei Qin,Fuju Tian,Xueqing Liu,Jianing Hu,Fan Wu,Cailian Chen,Yi Lin

DOI: https://doi.org/10.1186/s12916-024-03264-8

IF: 9.3

2024-02-07

BMC Medicine

Abstract:Abnormal placental development is a significant factor contributing to perinatal morbidity and mortality, affecting approximately 5–7% of pregnant women. Trophoblast syncytialization plays a pivotal role in the establishment and maturation of the placenta, and its dysregulation is closely associated with several pregnancy-related disorders, including preeclampsia and intrauterine growth restriction. However, the underlying mechanisms and genetic determinants of syncytialization are largely unknown.

medicine, general & internal

What problem does this paper attempt to address?

The paper aims to explore the issues of perinatal morbidity and mortality caused by abnormal placental development and to study the regulatory mechanisms of trophoblast cell syncytialization. Specifically, the paper identifies the key role of the histone methyltransferase MLL1 in the process of trophoblast cell syncytialization through drug screening. The main findings are as follows:

1. **Background Issue**: Abnormal placental development is one of the important factors leading to perinatal morbidity and mortality, affecting approximately 5-7% of pregnant women. Trophoblast cell syncytialization (i.e., the fusion of mononuclear trophoblast cells to form multinucleated syncytiotrophoblast cells) is a key step in placental formation, and its dysregulation is associated with various pregnancy-related diseases such as preeclampsia and intrauterine growth restriction.

2. **Research Objective**: Through systematic epigenetic drug screening, MLL1 was identified as an important factor regulating trophoblast cell syncytialization. MLL1 regulates trophoblast cell syncytialization and placental growth by modulating histone H3 lysine 4 trimethylation (H3K4me3), thereby affecting TEAD4 gene expression and the Hippo signaling pathway.

3. **Main Conclusions**: Knockdown or inhibition of MLL1 significantly promotes the formation of syncytiotrophoblast cells, while overexpression of MLL1 inhibits this process. Additionally, the study found that under hypoxic conditions, HIF1A can bind to and upregulate MLL1, activating the MLL1/TEAD4 axis, thereby affecting placental function. In vivo experiments showed that inhibiting MLL1 can significantly promote fetal vascular development and syncytial layer thickening, supporting placental growth.

In summary, this study reveals a new epigenetic mechanism of MLL1 in the process of trophoblast cell syncytialization and provides new insights for developing potential targets for the treatment of pregnancy-related diseases.